A Study to Improve the Awareness of Mucopolysaccharidosis Type II in Brazil
About this clinical trial
The main aims of the study are to learn about the percentage of mucopolysaccharidosis type II (MPS II) in adults in Brazil as well as about the diagnosis process. No study medicines will be provided to participants in this study. The data available for participants diagnosed with MPS II in DATASUS (a database of the Informatics Department of Brazilian Health System) will be reviewed. No clinic visits will be required as part of participation in this study.
At a glance
What medical conditions were being studied?
What was the clinical trial testing?
No Intervention
How many participants were enrolled?
250
Were placebos part of the clinical trial?
No
When was the clinical trial conducted?
Dec 2021 - Feb 2022
Key requirements
Sex
All
Age
All
Healthy volunteers?
No
Inclusion Criteria:
All MPS II cases of (International Classification of Diseases, 10th revision [ICD-10]
E76.1) at any age reported in DATASUS from January 1st, 2008 to September 30th, 2020 will
be included.
Exclusion Criteria:
MPS II cases reported outside this period will be excluded.